• Waqas Hameed
  • Iftekhar Yousaf
  • Rabia Latif
  • Muhammad Aslam


Background: Lower testosterone levels have been reported in men suffering from diabetes mellitus.Men with insulin resistance states such as obesity and type 2 diabetes mellitus have significantly lowertestosterone levels than age-matched normal weight and non-diabetic controls. Adipose tissue secretesvariety of adipokinesincluding adiponectin, resistin, visfatin, TNF-α. The study was designed to studythe effect of visfatin on testicular steroidogenesis in purified Leydig cell in vitro. Methods: Leydigcells of Sprague Dawley rats were isolated and purified by Percoll. Cells were incubated for 3 hourswith/without visfatin in the presence/absence of LH and intracellular signalling blockers including PKCblocker, PKA blocker and Raf1/Ras blocker. Cell culture extracts were stored at -80 ℃ before analysisfor levels of testosterone hormone by ELISA. Results: Visfatin increased testosterone production(p<0.001) from cultured Leydig cells. Raf1/Ras blocker decreased visfatin induced steroidogenesis(p<0.001). Conclusion: Visfatin increased testicular steroidogenesis from Leydig cells in vitro modelsand operates through variety of enzymes, but especially through Ras/Raf1 kinase enzymes.Keywords: Visfatin, adipocytokines, Leydig cells, testicular steroidogenesis


Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi

D, at al. Increasing insulin resistance is associated with a

decrease in Leydig cell testosterone secretion in men. J Clin

Endocrinol Metab 2005;90(5):2636–41.

Andersson B, Mårin P, Lissner L, Vermeulen A, Björntorp P.

Testosterone concentrations in women and men with NIDDM.

Diabetes Care 1994;17(5):405–11.

Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM. Sex

steroid hormones, upper body obesity, and insulin resistance. J

Clin Endocrinol Metab 2002;87(10):4522–7.

Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ. Association

of bioavailable, free, and total testosterone with insulin resistance:

influence of sex hormone-binding globulin and body fat.

Diabetes Care 2004;27(4):861–8.

Saez JM. Leydig cells: endocrine, paracrine, and autocrine

regulation. Endocr Rev 1994;15(5):574–626.

Lin T, Haskell J, Vinson N, Terracio L. Characterization of

insulin and insulin-like growth factor I receptors of purified

Leydig cells and their role in steroidogenesis in primary culture: a

comparative study. Endocrinology 1986;119(4):1641–7.

Bebakar WM, Honour JW, Foster D, Liu YL, Jacobs HS.

Regulation of testicular function by insulin and transforming

growth factor-beta. Steroids 1990;55(6):266–70.

Vettor R, De Pergola G, Pagano C, Englaro P, Laudadio E,

Giorgino F, et al. Gender differences in serum leptin in obese

people: relationships with testosterone, body fat distribution and

insulin sensitivity. Eur J Clin Invest 1997;27(12):1016–24.

Luukkaa V, Pesonen U, Huhtaniemi I, Lehtonen A, Tilvis R,

Tuomilehto J, et al. Inverse correlation between serum

testosterone and leptin in men. J Clin Endocrinol Metab


Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M,

Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that

mimics the effects of insulin. Science 2005;307(5708):426–30.

Sethi JK, Vidal-Puig A. Visfatin: the missing link between intraabdominal obesity and diabetes? Trends Mol Med


Zwain IH, Morris PL, Cheng CY. Identification of an inhibitory

factor from a Sertoli clonal cell line (TM4) that modulates adult

rat Leydig cell steroidogenesis. Mol Cell Endocrinol


Sharpe RM, Fraser HM. The role of LH in regulation of Leydig

cell responsiveness to an LHRH agonist. Mol Cell Endocrinol


Aldred LF. Cooke BA. The effect of cell damage on the density

and steroidogenic capacity of rat testis Leydig cells, using an

NADH exclusion test for determination of viability. J Steroid

Biochem 1983;18:411–4.

Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning

and characterization of the cDNA encoding a novel human preB-cell colony enhancing factor. Mol Cell Biol 1994;14:1431–7.

Gray RE, Tanner CJ, Pories WJ, MacDonald KG, Houmard JA.

Effect of weight loss on muscle lipid content in morbidly obese

subjects. Am J Physiol Endocrinol Metab 2003;284(4):E726–32.

Saez JM, Avallet O, Naville D, Perrard-Sapori MH, Chatelain

PG. Sertoli-Leydig cell communications. Ann NY Acad Sci


Varma V, Yao-Borengasser A, Rasouli N, Bodles AM,

Phanavanh B, Lee MJ, et al. Human visfatin expression:

relationship to insulin sensitivity, intramyocellular lipids, and

inflammation. J Clin Endocrinol Metab 2007;92(2):666–72.

Clark BJ. Wells J, King SR, Stocco DM. The purification,

cloning, and expression of a novel luteinizing hormone-induced

mitochondrial protein in MA-10 mouse Leydig tumor cells.

Characterization of the steroidogenic acute regulatory protein

(StAR). J Biol Chem 1994;269:28314–22.

Stocco DM, Clark BJ. Regulation of the acute production of

steroids in steroidogenic cells. Endocr Rev 1996;17:221–44.

Tena-Sempere M, Pinilla L, González LC, Diéguez C,

Casanueva FF, Aguilar E. Leptin inhibits testosterone secretion

from adult rat testis in vitro. J Endocrinol 1999;161(2):211–8.



Most read articles by the same author(s)

<< < 1 2